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Background
Sustaining research subject recruitment in biomedical
HIV prevention trials requires continual innovation.
Since June 2009, the University of Pennsylvania HIV
Vaccine Trials Unit (UPenn HVTU) has employed mul-
tiple strategies to recruit men who have sex with men
(MSM) for a phase IIb HIV vaccine trial, HVTN 505.
Methods
Between 12/1/2011 and 1/3/2012, the HVTU contracted
with a consumer marketing company to recruit potential
trial participants. For $3000, the company emailed MSM a
scripted message inviting them to participate in a clinical
HIV vaccine trial, and the company provided the trial site
with contact information for those who responded. Site
staff emailed and phoned each respondent to provide
study information and conduct a phone-screen interview
for the trial. Those eligible were scheduled for in-office
screening appointments.
Results
266 MSM were emailed; 118 viewed the message, and 109
responded that they were interested in participating. 83%
of responders were White, and 71% earned >$50,000/year.
Staff successfully contacted 64 individuals, and 58 com-
pleted phone-screens. Of these, 17 were eligible for, and 9
completed, screening visits. Five enrolled in HVTN 505
during January-February, 2012. Of 41 phone-screened
ineligible, primary reasons for ineligibility were: being
HIV-positive (n=20; 49%), not meeting protocol-specified
sexual risk criteria (n=11; 27%), out of age range (n=6;
15%), and/or being uncircumcised (n=5; 12%). Ineligible
participants were referred to phase I or future prevention
trials as appropriate.
Conclusion
This strategy reached MSM not engaged by previous
efforts, and doubled site HVTN 505 enrollment over two
months. Respondents included a higher proportion of
White MSM than the population screened for HVTN 505
at the HVTU. This approach has wider potential use for
recruitment in biomedical HIV prevention trials. To
understand the true utility of this approach, respondent
HIV risk data and financial costs associated with this strat-
egy must be carefully examined.
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